Literature DB >> 14529227

Clinical diabetic nephropathy in a tropical African population.

C O Alebiosu1.   

Abstract

Diabetic nephropathy is the single most important disorder leading to renal failure in adults in the Western countries and it is among the first three major causes of end stage renal disease in Nigeria. The aim of this study is to show the features of clinical diabetic nephropathy in the Olabisi Onabanjo University Teaching Hospital, Ogun State, Nigeria. The study group consists of 342 consecutive diabetic patients with persistent proteinuria (positive albustix) and diabetic retinopathy, seen from January 2000 to June 2001 in the Ogun State University Teaching Hospital, Sagamu. Clinical and laboratory parameters were recorded. Students' t-test and Spearman correlation coefficient were used in analysis. The frequency of occurrence of clinical diabetic nephropathy is 28.4% with majority already symptomatic despite normal biochemistry. Mean ages of type 1 and type 2 are 26+/-7.9 years and 53.4+/-6.3 years respectively with a sex ratio of 1.2:1. Mean duration of disease is 6.5+/-3.6 years and 9.4+/-4.1 years respectively. Two hundred and seventy-one (79.2%) patients were hypertensive. Nephrotic syndrome is not a common presentation. Diabetic nephropathy is a significant problem in this environment.

Entities:  

Mesh:

Year:  2003        PMID: 14529227     DOI: 10.4314/wajm.v22i2.27938

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  11 in total

1.  Diabetic nephropathy in Africa: A systematic review.

Authors:  Jean Jacques N Noubiap; Jashira Naidoo; Andre P Kengne
Journal:  World J Diabetes       Date:  2015-06-10

2.  Characteristics of end stage renal disease diabetic patients in two countries with different socioeconomic conditions.

Authors:  Emmanuel I Agaba; Oladipo Adeniyi; Karen S Servilla; Dorothy J Vanderjagt; Robert H Glew; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

3.  Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.

Authors:  Michael Olamoyegun; Waheed Ibraheem; Sandra Iwuala; Morenike Audu; Babatope Kolawole
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

4.  Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria.

Authors:  Julius U Okoye; Ejikeme B Arodiwe; Ifeoma I Ulasi; Chinwuba K Ijoma; Obinna D Onodugo
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

5.  Morbidity in relation to stage of diabetic nephropathy in type-2 diabetic patients.

Authors:  Christopher Olutayo Alebiosu; Olatunde Odusan; Alfred Jaiyesimi
Journal:  J Natl Med Assoc       Date:  2003-11       Impact factor: 1.798

6.  Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria.

Authors:  Kazeem B Yusuff; Olubunmi Obe; Bonatson Y Joseph
Journal:  Pharm World Sci       Date:  2008-09-11

7.  Serum C-peptide assay of patients with hyperglycemic emergencies at the Lagos State University Teaching Hospital (LASUTH), Ikeja.

Authors:  Akinyele Taofiq Akinlade; Anthonia Okeoghene Ogbera; Olufemi Adetola Fasanmade; Michael Adeyemi Olamoyegun
Journal:  Int Arch Med       Date:  2014-11-28

8.  Risk factors for chronic kidney disease among patients at Olabisi Onabanjo University Teaching Hospital in Sagamu, Nigeria: A retrospective cohort study.

Authors:  Temitope W Ladi-Akinyemi; Ikeoluwa Ajayi
Journal:  Malawi Med J       Date:  2017-06       Impact factor: 0.875

9.  Clinical Utility of Urinary β2-Microglobulin in Detection of Early Nephropathy in African Diabetes Mellitus Patients.

Authors:  U E Ekrikpo; E E Effa; E E Akpan; A S Obot; S Kadiri
Journal:  Int J Nephrol       Date:  2017-01-30

10.  Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008): Results of a multicenter study.

Authors:  Andrew E Uloko; Esther N Ofoegbu; Sunday Chinenye; Olufemi A Fasanmade; Adesoji A Fasanmade; Anthonia O Ogbera; Osi-Ogbu Ogbu; Johnnie M Oli; Bakari A Girei; Abdullahi Adamu
Journal:  Indian J Endocrinol Metab       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.